Kerry Clem

2022

In 2022, Kerry Clem earned a total compensation of $592.2K as Chief Commercial Officer at Acorda Therapeutics, a 11% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$168,075
Salary$415,000
Other$9,150
Total$592,225

Clem received $415K in salary, accounting for 70% of the total pay in 2022.

Clem also received $168.1K in non-equity incentive plan and $9.2K in other compensation.

Rankings

In 2022, Kerry Clem's compensation ranked 4,086th out of 5,756 executives tracked by ExecPay. In other words, Clem earned more than 29.0% of executives.

ClassificationRankingPercentile
All
4,086
out of 5,756
29th
Division
Manufacturing
2,306
out of 3,133
26th
Major group
Chemicals And Allied Products
1,117
out of 1,419
21st
Industry group
Drugs
1,048
out of 1,320
21st
Industry
Biological Products, Except Diagnostic Substances
247
out of 291
15th

Pay ratio

Kerry Clem's Pay$592,225
Median Employee's Pay$218,380
Pay Ratio

3

to 1

In 2022, the annual total compensation of Kerry Clem was $592,225.

The annual total compensation of the median employee at Acorda Therapeutics was $218,380.

The ratio of Kerry Clem's pay to the pay of median employee was therefore 3 to one.

Source: SEC filing on April 27, 2023.

Clem's colleagues

We found three more compensation records of executives who worked with Kerry Clem at Acorda Therapeutics in 2022.

2022

Ron Cohen

Acorda Therapeutics

Chief Executive Officer

2022

Lauren Sabella

Acorda Therapeutics

Chief Operating Officer

2022

Michael Gesser

Acorda Therapeutics

Chief Finance Officer and Treasurer

News

You may also like